The Israeli sick funds have increased patient copayments on prescriptions, in the majority of cases by 8.3%, which is the rise in the cost of living index since the last increase, in December 1995.
An average copayment is now a minimum of NIS6-NIS6.5 ($1.8-$2.0) for 10 tablets or an original pack (usually a month's treatment) or, in the case of the smaller funds, 10% of the retail price.
Furthermore, in the framework of the proposed Ministry of Health budget reductions, the Treasury has indicated that from next year, patients will have to pay NIS10 for a visit to a physician, NIS20 for a visit to an out-patient specialist, and NIS40 per day for hospitalization. There is also a proposal for a one-time 25% increase in the level of drug copayments.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze